| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.34 | 2e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 3e-06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.31 | 6e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |